Leavitt Chase C. 4
4 · Oncternal Therapeutics, Inc. · Filed Jan 5, 2023
Insider Transaction Report
Form 4
Leavitt Chase C.
General Counsel/Secretary
Transactions
- Tax Payment
Common Stock
2023-01-03$1.02/sh−6,091$6,213→ 81,901 total
Footnotes (1)
- [F1]Shares withheld by the Issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units.